You are here

Home › Listings › Life Sciences › Clearmind Medicine Inc.

Clearmind Medicine Inc.

Clearmind Medicine Inc.
Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
CMND
CSE Index: 
Currency: 

Clearmind develops novel psychedelic medicine based treatments to solve widespread, yet underserved health problems. With solid medical management and IP-protected treatments, the company aims to better the lives of millions of people.

You are here

Home

Clearmind Medicine Inc. (CMND)

SEDAR Information

Search form

Company Info

Address
101, 1220 W. 6th
Vancouver, BC V6H1A5
Canada
Phone
(604) 260 1566
Email
invest@clearmindmedicine.com
Listing date
Tuesday, May 15, 2018
Transfer Agent
Computershare Investor Services Inc.
Auditor
Brightman Almagor Zohar & Co.

Capitalization

Issued & Outstanding: 
3169614
Reserved for Issuance: 
3456180
Total equity shares, as if converted: 
6625794

Company Officers

Adi Zuloff-Shani, Chief Executive Officer
Alan Rootenberg, Chief Financial Officer

News Releases

13/03/2024

Clearmind Medicine Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities Exchange

29/02/2024

Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds

Bulletins

13/03/2024

2024-0317 - Delist - Clearmind Medicine Inc. (CMND)

le 13 mars/March 2024

The common shares of Clearmind Medicine Inc. will be delisted from the CSE at market close, March 14, 2024.

The common shares currently trade on Nasdaq.

___________________________

Les actions ordinaires de Clearmind Medicine Inc. seront radiées du CSE à la clôture du marché, le 14 mars 2024.

Les actions ordinaires se négocient actuellement au Nasdaq.

CSE Filings

Form 9

Form 11

Form 7

U.S. Only F-1 Registration Statement

January 2024 Form 11 RSU Issuance